Lenzner A, Koch E
Med Klin. 1979 May 25;74(21):834-8.
The efficacy and tolerance of Cefazedon, a new antibiotic, was investigated clinically on 90 patients with urinary tract infections who also required surgical treatment. Good clinical results were achieved in over 90% of patients after 6 to 7 days of treatment. The bacteriological examination revealed complete elimination of the initially identified pathogens in 89 cases. No difference in treatment results could be established when applying the dose 2 or 3 times daily. On the third day of treatment skin reactions were observed in one case which necessitated discontinuation of treatment. Laboratory blood values as well as control of liver and kidney function before treatment, after and one week past treatment showed no negative influence due to the drug. In approximately 27% a new colonisation mainly with Pseudomonas could not be prevented.
对一种新型抗生素头孢地嗪在90例需要手术治疗的尿路感染患者中进行了临床疗效和耐受性研究。治疗6至7天后,超过90%的患者取得了良好的临床效果。细菌学检查显示,89例患者最初鉴定出的病原体被完全清除。每日给药2次或3次时,治疗结果无差异。治疗第三天有1例出现皮肤反应,需要停药。治疗前、治疗后及治疗后一周的实验室血液值以及肝肾功能检查均未显示该药物有负面影响。约27%的患者无法预防主要由假单胞菌引起的新定植。